Alpha 2.0
Login Register
» Articles » PMID: 37432435

DNA Sequencing in Adults With Acute Myeloid Leukemia to Detect Residual Disease Prior to Hematopoietic Cell Transplant

Overview
Journal JAMA
Publisher American Medical Association
Specialty General Medicine
Date 2023 Jul 11
PMID 37432435
Authors
Niranjan Shiwaji Khaire
Dennis Dong Hwan Kim
Arjun D Law
Affiliations
Soon will be listed here.
Citing Articles

Quantification of the FLT3 internal tandem duplication is a reliable marker for monitoring measurable residual disease in acute myeloid leukemia with FLT3-ITD mutations.

Wang M, Huang S, Huang Y, Zhang J, Li H, Ge S Bone Marrow Transplant. 2024; 60(3):412-414.

PMID: 39658655 DOI: 10.1038/s41409-024-02495-w.

Measurable residual mutated IDH1 before allogeneic transplant for acute myeloid leukemia.

Gui G, Ravindra N, Hegde P, Andrew G, Mukherjee D, Wong Z Bone Marrow Transplant. 2024; 60(2):154-160.

PMID: 39506075 PMC: 11810766. DOI: 10.1038/s41409-024-02447-4.

Multi-target measurable residual disease assessed by error-corrected sequencing in patients with acute myeloid leukemia: An ALFA study.

Hirsch P, Lambert J, Bucci M, Deswarte C, Boudry A, Lambert J Blood Cancer J. 2024; 14(1):97.

PMID: 38871702 PMC: 11176326. DOI: 10.1038/s41408-024-01078-8.